Home Stock

Stock Research: Medpaces

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Medpaces

NasdaqGS:MEDP US58506Q1094
54
  • Value
    1
  • Growth
    100
  • Safety
    Safety
    9
  • Combined
    29
  • Sentiment
    37
  • 360° View
    360° View
    54
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medpace Holdings, Inc. is a global clinical contract research organization (CRO) providing full-service clinical development services. The company operates in the biotechnology, pharmaceutical, and medical device industries, offering phase I-IV clinical development services, bio-analytical laboratory services, clinical human pharmacology, imaging, and electrocardiography reading support. Their operations are principally based in North America, Europe, and Asia. In the last fiscal year, the company had a market cap of $8988 million, profits of $656 million, revenue of $2109 million, and 5900 employees.

more
Strongest Rank Value
Weakest Rank Growth
Country USA
Industry Life Sciences Tools & Services
Size Medium
Website investor.medpace.cominvestor-overview
Index
Employee Health US
NASDAQ
S&P MIDCAP
Medpaces stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 9 8 35
Growth
100 73 97 91
Safety
Safety
9 9 69 77
Sentiment
37 33 100 75
360° View
360° View
54 54 90 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
1 34 83 16
Opinions Change
21 22 50 50
Pro Holdings
n/a 56 92 92
Market Pulse
94 46 91 78
Sentiment
37 33 100 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 9 8 35
Growth
100 73 97 91
Safety Safety
9 9 69 77
Combined
29 29 65 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
24 32 38 67
Price vs. Earnings (P/E)
17 42 30 37
Price vs. Book (P/B)
3 17 3 33
Dividend Yield
1 1 1 1
Value
1 9 8 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
79 67 82 75
Profit Growth
61 33 73 51
Capital Growth
81 78 89 75
Stock Returns
95 59 87 75
Growth
100 73 97 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
100 100 62 100
Refinancing
7 8 3 13
Liquidity
1 1 100 90
Safety Safety
9 9 69 77

Similar Stocks

Discover high‑ranked alternatives to Medpaces and broaden your portfolio horizons.

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews